KIVIPRIDE-200 10X10

About

Kivipride-200 contains Amisulpride, an atypical antipsychotic medication primarily used in the treatment of acute and chronic schizophrenic disorders. At lower doses (e.g., 50-300mg), it acts as a selective dopamine D2/D3 receptor antagonist, preferentially blocking presynaptic dopamine autoreceptors, which leads to an increase in dopaminergic transmission. This mechanism is thought to be responsible for its efficacy in treating negative symptoms of schizophrenia and its antidepressant effects. At higher doses, it blocks postsynaptic D2/D3 receptors, effectively managing positive symptoms like hallucinations and delusions. Amisulpride has a relatively low propensity for extrapyramidal side effects compared to conventional antipsychotics.

Its unique pharmacological profile allows for a dose-dependent effect, making it versatile in managing the diverse symptomology of schizophrenia. The selective action on dopamine receptors contributes to its favorable side effect profile regarding motor symptoms, which are common with older antipsychotics. However, patients should be monitored for other potential side effects, including elevated prolactin levels and QT prolongation. Regular medical supervision is crucial to ensure optimal therapeutic outcomes and to manage any adverse reactions effectively.

Uses

• Treatment of acute and chronic schizophrenic disorders.
• Management of positive symptoms (e.g., delusions, hallucinations).
• Treatment of negative symptoms (e.g., apathy, social withdrawal).
• Adjunctive treatment for major depressive disorder (off-label in some regions).

Directions For Use

Take orally, usually once or twice daily, with or without food, as directed by your physician.

Benefits

• Effective against both positive and negative symptoms of schizophrenia.
• Lower incidence of extrapyramidal side effects compared to typical antipsychotics.
• May improve mood and social functioning.
• Can be beneficial for patients with predominant negative symptoms.
• Relatively good tolerability profile.
• Specific dopamine receptor selectivity.

Side Effects

• Insomnia
• Anxiety
• Agitation
• Sedation/Drowsiness
• Extrapyramidal symptoms (dose-dependent)
• Increased prolactin levels (galactorrhea, amenorrhea)
• Weight gain
• Dry mouth
• Constipation
• Nausea
• Dizziness
• QT prolongation

Safety Measures

• Alcohol - Avoid alcohol consumption as it can enhance the sedative effects of amisulpride and increase the risk of central nervous system depression.
• Pregnancy - Use during pregnancy is generally not recommended, especially in the third trimester, due to potential for withdrawal symptoms and extrapyramidal signs in the neonate. Consult a doctor.
• Breastfeeding - Amisulpride is excreted in breast milk. Breastfeeding is generally not recommended due to potential adverse effects on the infant.
• Liver - Generally, no specific dosage adjustment is required for liver impairment, but caution is advised in severe cases.
• Kidney - Dosage adjustments are necessary in patients with moderate to severe renal impairment due to reduced drug clearance.
• Lung - Generally safe for use in patients with stable lung conditions; however, monitor for any respiratory depression if co-administered with other CNS depressants.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.